Bachem Holding AG

December 20th, 2021 Innovative Companies

INNOVATION WORLD LARGE CAPS

December 2021

Swiss technology company Bachem Holding AG develops and produces ingredients for pharmaceuticals, generics, and research supplies. The company manufactures peptides and amino acids for drugs and laboratory research, as well as prescription drugs. Bachem sells its products to universities, pharmaceutical, and biotechnology companies worldwide and offers a comprehensive range of services.

Focus on Innovation

The innovation focus is on process innovations in the production of peptides. In collaboration with the company Belyntic, a catch-and-release platform called Peptide Easy Clean has been developed that enables the successful purification of peptides and extends previous functions. In addition, institutionalized platforms ensure the exchange of experience and knowledge within the company and thus support the innovation-focused corporate culture. As part of an active exchange with the relevant research community, Bachem seeks to identify new technologies at an early stage and actively shape their development. Besides, the company has high-quality standards and is characterized by continuous process improvement.

Every month ALPORA presents an ALPORA Top Innovator for each innovation fund. For each company, a detailed innovation analysis was carried out based on the ALPORA-Methods and the resulting innovation efficiency score was determined.